Scientists have discovered clues which may explain why some treatments stop working for people with bowel cancer – causing around 16,800 deaths in the UK every year. The study, led by researchers at ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer. Research published in the journal Blood ...

New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatmentResearchers have developed a new tool that could help clinicians diagnose the most common ...

News from ASCO 2025 From 30 May to 3 June, the world’s leading oncologists and researchers, including scientists from The Institute of Cancer Research, London, will converge at the 2025 American ...

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

A new frontier in cancer research: the rise of radiotheranostics Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer ...

ICR welcomes approval for new ovarian cancer drug combinationThe Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous. They have shown exactly how telomeres – the protective ...

ICR welcomes NICE recommendation of capivasertib for advanced breast cancerThe Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...